Short-Term Androgen Suppression Improves PFS After Radical Prostatectomy for Prostate Cancer Short-Term Androgen Suppression Improves PFS After Radical Prostatectomy for Prostate Cancer

Short-term androgen deprivation therapy added to radiotherapy as salvage therapy after radical prostatectomy for prostate cancer improves 10-year progression-free survival, according to a follow-up of the GETUG-AFU 16 phase 3 trial.Reuters Health Information
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Hematology-Oncology News Source Type: news